<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04346537</url>
  </required_header>
  <id_info>
    <org_study_id>92424682</org_study_id>
    <nct_id>NCT04346537</nct_id>
  </id_info>
  <brief_title>INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study</brief_title>
  <official_title>INGEVITY+ Active Fixation Pace/Sense Lead Clinical Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is it to confirm the safety and effectiveness of the INGEVITY+&#xD;
      Active Fixation Pace/Sense Lead.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 6, 2020</start_date>
  <completion_date type="Actual">March 1, 2021</completion_date>
  <primary_completion_date type="Actual">March 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety: Lead-related Complication-Free Rate</measure>
    <time_frame>Lead Implant through 3-Months Post-Implant</time_frame>
    <description>Lead-related Complication-Free Rate</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Primary Effectiveness: Pacing Capture Threshold Responder Rate</measure>
    <time_frame>At 3-Months Post-Implant</time_frame>
    <description>Pacing Capture Threshold Responder Rate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Sensed Amplitude in mV</measure>
    <time_frame>At 3-Months Post-Implant</time_frame>
    <description>Sensed Amplitude in mV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary Effectiveness: Pacing Impedance in Ohms</measure>
    <time_frame>At 3-Months Post-Implant</time_frame>
    <description>Pacing Impedance in Ohms</description>
  </secondary_outcome>
  <enrollment type="Actual">109</enrollment>
  <condition>Bradycardia</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>INGEVITY+â„¢ Pace/Sense Lead</intervention_name>
    <description>The INGEVITY+ lead is indicated for chronic pacing and sensing in the right atrium and/or right ventricle when used with a compatible pulse generator.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be selected from the investigator's general patient population indicated for&#xD;
        dual-chamber pacemaker or CRT-P implantation.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject is willing and capable of providing informed consent&#xD;
&#xD;
          2. Subject is intended to undergo initial (de novo) pacing system implant using INGEVITY+&#xD;
             Leads in the Right Atrium (RA) and Right Ventricle (RV) and a Boston Scientific pulse&#xD;
             generator&#xD;
&#xD;
          3. Subject meets an indication for a Boston Scientific Pacemaker or CRT-P device per&#xD;
             product labeling (Physician's Technical Manual)&#xD;
&#xD;
          4. Willing and capable of participating in all testing/visits associated with this&#xD;
             clinical study at an approved clinical study center and at the intervals defined by&#xD;
             this protocol&#xD;
&#xD;
          5. Age 18 or above, or of legal age to give informed consent specific to state and&#xD;
             national law&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Known or suspected sensitivity to dexamethasone acetate (DXA)&#xD;
&#xD;
          2. Has a mechanical tricuspid heart valve&#xD;
&#xD;
          3. Women of childbearing potential who are or might be pregnant at the time of study&#xD;
             enrollment or INGEVITY+ Lead implant (method of assessment upon physician's&#xD;
             discretion)&#xD;
&#xD;
          4. Currently requiring hemo- or peritoneal dialysis&#xD;
&#xD;
          5. Subject has or has had implanted any pacing or ICD system, including subcutaneous,&#xD;
             transvenous or leadless systems&#xD;
&#xD;
          6. Intended to receive a single chamber device&#xD;
&#xD;
          7. Documented history of permanent or persistent AF&#xD;
&#xD;
          8. Currently on an active organ transplant list&#xD;
&#xD;
          9. Documented life expectancy of less than 12 months&#xD;
&#xD;
         10. Enrolled in any other concurrent study unless prior approval is received from the&#xD;
             Sponsor&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Devi Nair, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nair Associates, LLC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Center Research, LLC</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nair Research, LLC</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Torrance Memorial Medical Center</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Iowa Hospitals and Clinics</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Institute of Michigan</name>
      <address>
        <city>Clinton Township</city>
        <state>Michigan</state>
        <zip>48048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cox Health</name>
      <address>
        <city>Springfield</city>
        <state>Missouri</state>
        <zip>65807</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catholic Medical Center</name>
      <address>
        <city>Manchester</city>
        <state>New Hampshire</state>
        <zip>03102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Deborah Heart and Lung</name>
      <address>
        <city>Browns Mills</city>
        <state>New Jersey</state>
        <zip>08015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aultman Hospital</name>
      <address>
        <city>Canton</city>
        <state>Ohio</state>
        <zip>44710</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Thomas Health</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sentara Norfolk General Hospital</name>
      <address>
        <city>Norfolk</city>
        <state>Virginia</state>
        <zip>23507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>PeaceHealth Southwest Medical</name>
      <address>
        <city>Bellingham</city>
        <state>Washington</state>
        <zip>98664</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>April 8, 2020</study_first_submitted>
  <study_first_submitted_qc>April 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2020</study_first_posted>
  <last_update_submitted>March 16, 2021</last_update_submitted>
  <last_update_submitted_qc>March 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bradycardia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

